Answers are grounded in this paper and cite their sources.
BACKGROUNDColorectal cancer (CRC) remains among the malignancies with the highest global incidence and cancer-related mortality rates, while current therapeutic strategies continue to face challenges, including limited efficacy and considerable systemic toxicity.Shaoyao decoction (SYD), a classical traditional Chinese medicine formula, has shown promising therapeutic potential for CRC; however, its underlying mechanisms remain largely unclear.AIM To elucidate the mechanisms by which SYD reshapes the immunosuppressive tumor microenvironment in CRC, using combined in vivo and in vitro experiments.METHODS An integrative approach combining an MC38 tumor-bearing mouse model, bone marrow-derived myeloid-derived suppressor cell-tumor (MDSC-tumor) cell co-culture system, flow cytometry, immunohistochemistry, western blotting, network pharmacology, molecular docking, molecular dynamics (MD) simulation, and untargeted metabolomics was used to investigate the therapeutic effects and mechanisms of SYD in CRC.RESULTS SYD significantly inhibited tumor growth in MC38 tumor-bearing mice, accompanied by reduced tumor tissue proliferation and enhanced apoptosis, without causing apparent hepatotoxicity or nephrotoxicity.SYD remodeled the tumor immune microenvironment by reducing the abnormal accumulation of MDSCs in tumor tissues and spleens, enhancing antitumor immune responses, and alleviating immunosuppressive states.In 5 / 53 vitro, SYD suppressed MC38 cell proliferation, migration, invasion, and epithelialmesenchymal transition, while promoting apoptosis.In the MDSC-tumor cell co-culture system, SYD attenuated MDSC-mediated tumor-promoting effects, which may be partially associated with down-regulated hypoxia-inducible factor 1α (HIF-1α) in MDSCs and reduced immunosuppressive function.Network pharmacology analysis, a computational and hypothesis-generating approach, pointed to HIF-1α signaling as apotentially key regulatory pathway that may be involved in the antitumor activity of SYD.Molecular docking and MD simulations provided additional in-silico support for a potentially stable interaction between SYD-derived active compounds and HIF-1α.Metabolomic analysis demonstrated that SYD modulated metabolic networks associated with lipid metabolism and bile acid metabolism.CONCLUSION SYD suppresses colorectal cancer progression in the MC38 mouse model by reversing the MDSC-mediated immunosuppressive tumor microenvironment and inhibiting tumor growth, an effect that may be associated with suppression of HIF-1α signaling in MDSCs.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: